kabutan

Chiome Bioscience, Last Fiscal Year's Net Income Loss Narrows, Current period performance is undisclosed.

Tue Feb 10, 2026 5:00 pm JST Earnings

4583 Chiome Bioscience Inc. 【J-GAAP】

Earnings Report

Chiome Bioscience Inc. <4583> [TSE Growth] announced its financial results after the market closed on February 10th (17:00). The net loss (non-consolidated) for the fiscal year ended December 2025 was loss of 0.98 billion yen, a reduction in the deficit compared to loss of 1.02 billion yen in the previous term. This marks the eleventh consecutive term of losses. Furthermore, the company did not disclose the performance outlook for the fiscal year ending December 2026.

In the most recent three-month period, from October to December (4Q), the net loss expanded to a loss of 0.18 billion yen (compared to a loss of 0.10 billion yen in the same period last year). The operating profit/loss margin drastically worsened from -30.7% in the same period last year to -77.7%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 682 -1,205 -1,217 -1,220 -24.6 0 Feb 13, 2024 J-GAAP
Dec, 2024 780 -1,030 -1,019 -1,020 -17.5 0 Feb 13, 2025 J-GAAP
Dec, 2025 593 -979 -989 -982 -14.5 0 Feb 10, 2026 J-GAAP
YoY -24.0% +5.0% +2.9% +3.7% +17.5%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2025 Guidance ー ー ー ー － 0 Feb 13, 2025 J-GAAP
Dec, 2025 Results 593 -979 -989 -982 -14.5 0 Feb 10, 2026 J-GAAP
Revision Rate － － － － －

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 251 -536 -539 -540 -8.0 0 Aug 12, 2025 J-GAAP
Jan - Jun, 2026 Guidance ー ー ー ー － 0 Feb 10, 2026 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 780 -1,030 -1,019 -1,020 -17.5 0 Feb 13, 2025 J-GAAP
Dec, 2025 593 -979 -989 -982 -14.5 0 Feb 10, 2026 J-GAAP
Dec, 2026 Guidance ー ー ー ー － 0 Feb 10, 2026 J-GAAP
YoY － － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 358 -110 -105 -105 -1.8 -30.7 Feb 13, 2025 J-GAAP
Jan - Mar, 2025 138 -264 -265 -266 -3.9 -191.3 May 12, 2025 J-GAAP
Apr - Jun, 2025 113 -272 -274 -274 -4.0 -240.7 Aug 12, 2025 J-GAAP
Jul - Sep, 2025 118 -269 -268 -260 -3.8 -228.0 Nov 11, 2025 J-GAAP
Oct - Dec, 2025 224 -174 -182 -182 -2.7 -77.7 Feb 10, 2026 J-GAAP
YoY -37.4% -58.2% -73.3% -73.3% -48.1%

Related Articles